- Home
- BEAT vs ISPO Comparison
BEAT vs ISPO Comparison
Compare BEAT & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- ISPO
- Stock Information
- Founded
- BEAT 2015
- ISPO 2010
- Country
- BEAT United States
- ISPO United States
- Employees
- BEAT N/A
- ISPO N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- ISPO Blank Checks
- Sector
- BEAT Technology
- ISPO Finance
- Exchange
- BEAT Nasdaq
- ISPO Nasdaq
- Market Cap
- BEAT 51.1M
- ISPO 44.3M
- IPO Year
- BEAT 2021
- ISPO N/A
- Fundamental
- Price
- BEAT $1.27
- ISPO $2.82
- Analyst Decision
- BEAT Buy
- ISPO
- Analyst Count
- BEAT 1
- ISPO 0
- Target Price
- BEAT $8.00
- ISPO N/A
- AVG Volume (30 Days)
- BEAT 71.4K
- ISPO 45.9K
- Earning Date
- BEAT 08-13-2025
- ISPO 08-12-2025
- Dividend Yield
- BEAT N/A
- ISPO N/A
- EPS Growth
- BEAT N/A
- ISPO N/A
- EPS
- BEAT N/A
- ISPO N/A
- Revenue
- BEAT N/A
- ISPO $265,499,000.00
- Revenue This Year
- BEAT N/A
- ISPO N/A
- Revenue Next Year
- BEAT N/A
- ISPO $148.67
- P/E Ratio
- BEAT N/A
- ISPO N/A
- Revenue Growth
- BEAT N/A
- ISPO N/A
- 52 Week Low
- BEAT $1.17
- ISPO $2.67
- 52 Week High
- BEAT $3.48
- ISPO $9.31
- Technical
- Relative Strength Index (RSI)
- BEAT 38.33
- ISPO 30.53
- Support Level
- BEAT $1.24
- ISPO $3.00
- Resistance Level
- BEAT $1.34
- ISPO $3.23
- Average True Range (ATR)
- BEAT 0.07
- ISPO 0.27
- MACD
- BEAT 0.01
- ISPO -0.06
- Stochastic Oscillator
- BEAT 41.18
- ISPO 12.86
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.